CRISPR Therapeutics to Participate in the Canaccord Genuity 41st Annual Growth Conference

NEXT STORY
Novan to Report Second Quarter 2021 Financial Results on August 12, 2021
PREV STORY
Allergies in Primary Care: A Study of the Allergy Management Evaluation Tool Published on Consultant360 Specialty Network
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly

author_avatar
NASDAQ Market News

GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients

author_avatar
NASDAQ Market News

Phathom Pharmaceuticals Submits Two NDAs to U.S. FDA for Vonoprazan-based Treatment Regimens for the Treatment of H. pylori Infection

author_avatar
NASDAQ Market News